Healthcare - Biotechnology - NASDAQ - US
$ 4.21
-1.41 %
$ 251 M
Market Cap
-5.61
P/E
Price Target
Average
153.37%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
56.02%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Aldeyra Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ALDX of $10.7 , with forecasts ranging from a low of $10 to a high of $12 .
ALDX Lowest Price Target
Wall Street Target
10 USD
137.53%
ALDX Average Price Target
Wall Street Target
10.7 USD
153.37%
ALDX Highest Price Target
Wall Street Target
12 USD
185.04%
REVENUE FORECAST
Revenue Forecast Chart ALDX
EBIT FORECAST
EBIT Forecast Chart ALDX
NET INCOME FORECAST
Net Income Chart ALDX